Concerto Biosciences creates breakthrough microbe-based products originating from our unmatched understanding of microbial ecology. Microbes in, on, and around us work in concert to improve human health, enhance food quality, and boost crop yield. Designing products that recapitulate these functions requires an unprecedented grasp of how microbes interact with each other and their environments. Concerto unlocks this knowledge with kChip―a versatile technology that physically constructs millions of miniature, defined microbial cocultures simultaneously, thereby fueling rapid discovery of transformative microbial, prebiotic, or postbiotic products. Concerto’s lead product candidate, Ensemble No.2 (ENS-002), is a topical, multi-strain live biotherapeutic product (LBP) being developed to prevent the bacterium S. aureus from overgrowing and secreting toxins, an underlying cause of atopic dermatitis. Our internal pipeline also covers women’s health and innovation in the gut microbiome.